IN BRIEF: Oxford BioDynamics Covid severity tests available in US
IN BRIEF: Oxford BioDynamics Covid severity tests available in US
Read moreIN BRIEF: Oxford BioDynamics Covid severity tests available in US
Read moreDIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning
Read moreDIRECTOR DEALINGS: Croda general counsel sells GBP200,000 in shares
Read moreIN BRIEF: Oxford BioDynamics director Diggle raises stake to 15%
Read moreTRADING UPDATES: Ridgecrest ends Blue Air deal; Vast's Baita Plai hit
Read moreTRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live
Read more(Sharecast News) - Oxford BioDynamics has been awarded an FNIH Partnership for Accelerating Cancer Therapies (PACT) grant, it announced on Tuesday, to use its 'EpiSwitch' diagnostic platform for the accurate prediction of a patient's response to immune checkpoint inhibitors (ICIs) from a routine blood sample.
Read moreTRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit view
Read moreUK earnings, trading statements calendar - next 7 days
Read moreOxford BioDynamics "significantly" expands UK facilities with new lab
Read moreIN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent
Read more(Sharecast News) - Biotechnology company Oxford BioDynamics has signed a supply and resale agreement with US firm Agilent Technologies for the manufacture and sale of its new EpiSwitch Explorer Array Kit.
Read moreAIM WINNERS & LOSERS: Time Out ditches Waterloo market, plans raise
Read moreIN BRIEF: Oxford BioDynamics launches Covid-19 severity test in US
Read moreUK shareholder meetings calendar - next 7 days
Read more